전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleWuhan Sian Medical Technology C…Phase 2

Second generation CAR-T cells (Second generation CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Active
CGTLimited DatastaleHistograft Co., Ltd.Preclinical

"Histograft", a bone substitute based on octacalcium phosphate (OCP, "Histograft", a bone substitute based on octacalcium phosphate, "Histograft", a bone substitute based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA gene)

Non Union Fracture; Non-Union of Ankle Joint Without Infection · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 45Status Active
AntibodyLimited DatastaleGruppo Oncologico del Nord-OvestPhase 2

Balstilimab (Balstilimab)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#ResectableColorectalCarcinoma+1
Trials 45Status Recruiting
CGTLimited DatastaleAcrotech Biopharma Inc.Phase 1

Belinostat (Belinostat)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 45Status Discontinued
CGTLimited DatastaleSecuraBioPhase 1

Duvelisib (Duvelisib)

Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 45Status Active
AntibodyLimited DatastaleIndiana Hemophilia &Thrombosis …Approved

Emicizumab (Emicizumab)

Haemophilic Pseudotumour · Factor VIII Deficiency, Congenital

#FactorVIIIDeficiencyCongenital#Antibody#Approved#monoclonal-antibody#HaemophilicPseudotumour+2
Trials 45Status Discontinued
CGTLimited DatastaleNovartisPhase 3

tisagenlecleucel (Kymriah, tisa-cel)

DLBCL; Diffuse Large B Cell Lymphoma · FRα

#FR#CGT#Phase3#cell-gene-therapy#CAR-T+5
Trials 45Status Recruiting
CGTLimited DatastaleInnovative Cellular Therapeutic…Phase 2

CART-19 (CART-19)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 44Status Active
AntibodyLimited DatastaleNew Approaches to Neuroblastoma…Phase 1

Dinutuximab (Dinutuximab)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#Antibody#Phase1#monoclonal-antibody#NKcellsbyacombinatorialimmunothe+1
Trials 44Status Recruiting
AntibodyLimited DatastaleJack Khouri, MDPhase 2

Siltuximab (Siltuximab)

Multiple Myeloma; Cytokine Release Syndrome · Myelofibrosis

#Myelofibrosis#Antibody#Phase2#monoclonal-antibody#MultipleMyeloma+3
Trials 43Status Recruiting
AntibodyCurated CorestaleLEO PharmaApproved

Tralokinumab (Tralokinumab)

Psoriasis; Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+3
Trials 43Status Recruiting
CGTLimited DatastaleThe Methodist Hospital Research…Phase 2

gene therapy (ADV/HSV-tk, ADV/HSV-tk (gene therapy))

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 42Status Recruiting
AntibodyLimited DatastaleHuiKai LiPhase 2

Pucotenlimab (Pucotenlimab)

Biliary Tract Cancer (BTC); EGFR-positive Advanced Biliary Tract Carcinoma · Nasopharyngeal Cancinoma (NPC)

#NasopharyngealCancinomaNPC#Antibody#Phase2#monoclonal-antibody#BiliaryTractCancerBTC+2
Trials 42Status Recruiting
ADCLimited DatastaleMerck Sharp & Dohme LLCDeruxtecan in Patients With…Phase 2

I-DXd (Ifinatamab Deruxtecan, Ifinatamab Deruxtecan (I-DXd))

Carcinoma, Non-Small-Cell Lung · Small-Cell Lung Cancer

#Small-CellLungCancer#ADC#Phase2#antibody-drug-conjugate#Carcinoma+4
Trials 41Status Recruiting
AntibodyLimited DatastaleAlmirall, S.A.Approved

Tildrakizumab (Tildrakizumab)

Psoriasis; Atopic Dermatitis · Psoriasis

#Psoriasis#Antibody#Approved#monoclonal-antibody#AtopicDermatitis+1
Trials 41Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Ocrelizumab, Rituximab, Ofatumumab (Anti-CD20 therapies, Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab))

Relapsing-Remitting Multiple Sclerosis (RRMS); Anti-CD20 Therapy · CD20

#CD20#Antibody#Phase3#monoclonal-antibody#Relapsing-RemittingMultipleScler+3
Trials 40Status Recruiting
CGTLimited DatastaleOHSU Knight Cancer InstitutePhase 2

Hyper-CVAD (Hyper-CVAD)

Relapsed/Refractory; B-cell Acute Lymphocytic Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 40Status Recruiting
AntibodyCurated CorestaleJanssenPhase 3

Talquetamab (Talquetamab)

Myeloma Multiple; Plasma Cell Leukemia · FRα

#FR#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+4
Trials 40Status Discontinued
CGTLimited DatastaleImmunityBio, Inc.Phase 2

haNK (haNK)

Melanoma · Merkel Cell Carcinoma

#MerkelCellCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 40Status Discontinued
AntibodyLimited DatastaleRegeneron PharmaceuticalsPhase 2

Fianlimab (Fianlimab)

Ovarian Cancer; Fallopian Tube Cancer · NSCLC

#NSCLC#Antibody#Phase2#monoclonal-antibody#OvarianCancer+3
Trials 39Status Recruiting

13 / 103 pages

← PreviousNext →